{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:46:33Z","timestamp":1790196393395,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12026-022-09352-2","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T22:09:44Z","timestamp":1671401384000},"page":"287-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Lipocalin 2\u2014not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials"],"prefix":"10.1007","volume":"71","author":[{"given":"Sumaira","family":"Asaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazeela","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouina","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-5745","authenticated-orcid":false,"given":"Azza","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Cherrez","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"9352_CR1","first-page":"601","volume":"4","author":"S Hraba-Renevey","year":"1989","unstructured":"Hraba-Renevey S, T\u00fcrler H, Kress M, Salomon C, Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene. 1989;4:601\u20138.","journal-title":"Oncogene"},{"key":"9352_CR2","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengel\u00f8v H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem ASBMB. 1993;268:10425\u201332.","journal-title":"J Biol Chem ASBMB"},{"key":"9352_CR3","doi-asserted-by":"crossref","unstructured":"Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. 1994;83:799\u2013807.","DOI":"10.1182\/blood.V83.3.799.bloodjournal833799"},{"key":"9352_CR4","doi-asserted-by":"crossref","unstructured":"Flower DR, North ACT, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta (BBA)-Protein Struct Mol Enzymol. Elsevier; 2000;1482:9\u201324.","DOI":"10.1016\/S0167-4838(00)00148-5"},{"key":"9352_CR5","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/jgh.12597","volume":"29","author":"RM Janas","year":"2014","unstructured":"Janas RM, Ochoci\u0144ska A, \u015anitko R, Dudka D, Kierku\u015b J, Teisseyre M, et al. Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease. J Gastroenterol Hepatol Wiley Online Library. 2014;29:1883\u20139.","journal-title":"J Gastroenterol Hepatol Wiley Online Library"},{"key":"9352_CR6","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta (BBA)-Reviews Cancer. Elsevier; 2012;1826:129\u201369.","DOI":"10.1016\/j.bbcan.2012.03.008"},{"key":"9352_CR7","first-page":"6630","volume":"171","author":"JB Cowland","year":"2003","unstructured":"Cowland JB, S\u00f8rensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1\u03b2, but not by TNF-\u03b1. J Immunol Am Assoc Immnol. 2003;171:6630\u20139.","journal-title":"J Immunol Am Assoc Immnol"},{"key":"9352_CR8","first-page":"917","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nat Nat Publ Group. 2004;432:917\u201321.","journal-title":"Nat Nat Publ Group"},{"key":"9352_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1359-6446(04)03294-5","volume":"10","author":"S Schlehuber","year":"2005","unstructured":"Schlehuber S, Skerra A. Lipocalins in drug discovery: from natural ligand-binding proteins to \u2018anticalins.\u2019 Drug Discov Today Elsevier. 2005;10:23\u201333.","journal-title":"Drug Discov Today Elsevier"},{"key":"9352_CR10","first-page":"829","volume":"293","author":"LR Devireddy","year":"2001","unstructured":"Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Sci (80-) Am Assoc Adv Sci. 2001;293:829\u201334.","journal-title":"Sci (80-) Am Assoc Adv Sci"},{"key":"9352_CR11","first-page":"2533","volume":"56","author":"Q-W Yan","year":"2007","unstructured":"Yan Q-W, Yang Q, Mody N, Graham TE, Hsu C-H, Xu Z, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes Am Diabetes Assoc. 2007;56:2533\u201340.","journal-title":"Diabetes Am Diabetes Assoc"},{"key":"9352_CR12","first-page":"785","volume":"43","author":"CS Hau","year":"2016","unstructured":"Hau CS, Kanda N, Tada Y, Shibata S, Uozaki H, Fukusato T, et al. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response. J Dermatol Wiley Online Library. 2016;43:785\u201394.","journal-title":"J Dermatol Wiley Online Library"},{"key":"9352_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu Rev Nutr Annual Reviews. 2017;37:103\u201330.","journal-title":"Annu Rev Nutr Annual Reviews"},{"key":"9352_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044328","volume-title":"Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation","author":"B Chassaing","year":"2012","unstructured":"Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. USA: Public Library of Science San Francisco; 2012."},{"key":"9352_CR15","first-page":"565","volume":"20","author":"V Abella","year":"2015","unstructured":"Abella V, Scotece M, Conde J, G\u00f3mez R, Lois A, Pino J, et al. The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers Taylor & Francis. 2015;20:565\u201371.","journal-title":"Biomarkers Taylor & Francis"},{"key":"9352_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1353\/pbm.1997.0072","volume":"40","author":"ED Weinberg","year":"1997","unstructured":"Weinberg ED. The Lactobacillus anomaly: total iron abstinence. Perspect Biol Med Johns Hopkins Univ Press. 1997;40:578\u201383.","journal-title":"Perspect Biol Med Johns Hopkins Univ Press"},{"key":"9352_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcmgh.2016.03.007","volume":"2","author":"V Singh","year":"2016","unstructured":"Singh V, San Yeoh B, Chassaing B, Zhang B, Saha P, Xiao X, et al. Microbiota-inducible innate immune siderophore binding protein lipocalin 2 is critical for intestinal homeostasis. Cell Mol Gastroenterol Hepatol Elsevier. 2016;2:482\u201398.","journal-title":"Cell Mol Gastroenterol Hepatol Elsevier"},{"key":"9352_CR18","first-page":"3909","volume":"117","author":"M Vijay-Kumar","year":"2007","unstructured":"Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest Am Soc Clin Investig. 2007;117:3909\u201321.","journal-title":"J Clin Invest Am Soc Clin Investig"},{"key":"9352_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1006\/cyto.2000.0716","volume":"12","author":"WJS de Villiers","year":"2000","unstructured":"de Villiers WJS, Varilek GW, de Beer FC, Guo J-T, Kindy MS. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine Elsevier. 2000;12:1337\u201347.","journal-title":"Cytokine Elsevier"},{"key":"9352_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1365-2362.1987.tb01143.x","volume":"17","author":"RE Chambers","year":"1987","unstructured":"Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest Wiley Online Libr. 1987;17:460\u20137.","journal-title":"Eur J Clin Invest Wiley Online Libr"},{"key":"9352_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1369\/jhc.2009.953257","volume":"57","author":"H Cho","year":"2009","unstructured":"Cho H, Kim J-H. Lipocalin 2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer. J Histochem Cytochem SAGE Publications Sage CA: Los Angeles, CA. 2009;57:513\u201321.","journal-title":"J Histochem Cytochem SAGE Publications Sage CA: Los Angeles, CA"},{"key":"9352_CR22","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1073\/pnas.0810617106","volume":"106","author":"J Yang","year":"2009","unstructured":"Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, et al. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci Nal Acad Sci. 2009;106:3913\u20138.","journal-title":"Proc Natl Acad Sci Nal Acad Sci"},{"key":"9352_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2215\/CJN.03530708","volume":"4","author":"D Bolignano","year":"2009","unstructured":"Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol Am Soc Nephrol. 2009;4:337\u201344.","journal-title":"Clin J Am Soc Nephrol Am Soc Nephrol"},{"key":"9352_CR24","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1158\/0008-5472.CAN-09-1934","volume":"69","author":"X Leng","year":"2009","unstructured":"Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res AACR. 2009;69:8579\u201384.","journal-title":"Cancer Res AACR"},{"key":"9352_CR25","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.1073\/pnas.0710846105","volume":"105","author":"A Iannetti","year":"2008","unstructured":"Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-\u03baB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci Natl Acad Sci. 2008;105:14058\u201363.","journal-title":"Proc Natl Acad Sci Natl Acad Sci"},{"key":"9352_CR26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3748\/wjg.v16.i12.1500","volume":"16","author":"CL Sampieri","year":"2010","unstructured":"Sampieri CL, De La Pe\u00f1a S, Ochoa-Lara M, Zenteno-Cuevas R, Le\u00f3n-C\u00f3rdoba K. Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis. World J Gastroenterol WJG Baishideng Publ Group Inc. 2010;16:1500.","journal-title":"World J Gastroenterol WJG Baishideng Publ Group Inc"},{"key":"9352_CR27","first-page":"1540","volume":"98","author":"N Moniaux","year":"2008","unstructured":"Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer Nature Publ Group. 2008;98:1540\u20137.","journal-title":"Br J Cancer Nature Publ Group"},{"key":"9352_CR28","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/0008-5472.CAN-08-0540","volume":"68","author":"Z Tong","year":"2008","unstructured":"Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, et al. Neutrophil gelatinase\u2013associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res AACR. 2008;68:6100\u20138.","journal-title":"Cancer Res AACR"},{"key":"9352_CR29","first-page":"414","volume":"38","author":"BS Nielsen","year":"1996","unstructured":"Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut BMJ Publ Group. 1996;38:414\u201320.","journal-title":"Gut BMJ Publ Group"},{"key":"9352_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin Wiley Online Libr. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin Wiley Online Libr"},{"key":"9352_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin Wiley Online Libr. 2007;57:43\u201366.","journal-title":"CA Cancer J Clin Wiley Online Libr"},{"key":"9352_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-008-9892-4","volume":"319","author":"H Cho","year":"2008","unstructured":"Cho H, Kang ES, Hong SW, Oh YJ, Choi SM, Kim SW, et al. Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line. Mol Cell Biochem Springer. 2008;319:189\u2013201.","journal-title":"Mol Cell Biochem Springer"},{"key":"9352_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","volume":"58","author":"H Cho","year":"2009","unstructured":"Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother Springer. 2009;58:15\u201323.","journal-title":"Cancer Immunol Immunother Springer"},{"key":"9352_CR34","doi-asserted-by":"publisher","unstructured":"Noto A, Cibecchini F, Fanos V, Mussap M. NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed Res Int. Hindawi; 2013;2013:612032. https:\/\/doi.org\/10.1155\/2013\/612032.","DOI":"10.1155\/2013\/612032"},{"key":"9352_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5812\/numonthly.9385","volume":"5","author":"Z Rostami","year":"2013","unstructured":"Rostami Z, Nikpoor M, Einollahi B. Urinary neutrophil gelatinase associated lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephrourol Mon Kowsar Med Inst. 2013;5:745.","journal-title":"Nephrourol Mon Kowsar Med Inst"},{"key":"9352_CR36","doi-asserted-by":"publisher","unstructured":"Hostetter TH. Progression of renal disease and renal hypertrophy. Annu Rev Physiol. Annual Reviews 4139 El Camino Way, PO Box 10139, Palo Alto, CA 94303\u20130139, USA; 1995;57:263\u201378. https:\/\/doi.org\/10.1146\/annurev.ph.57.030195.001403.","DOI":"10.1146\/annurev.ph.57.030195.001403"},{"key":"9352_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pop.2008.01.008","volume":"35","author":"R Thomas","year":"2008","unstructured":"Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim care Clin Off Pract Elsevier. 2008;35:329\u201344.","journal-title":"Prim care Clin Off Pract Elsevier"},{"key":"9352_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI27699","volume":"116","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest Am Soc Clin Investig. 2006;116:288\u201396.","journal-title":"J Clin Invest Am Soc Clin Investig"},{"key":"9352_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1523-1755.2003.00058.x","volume":"64","author":"L-J Ma","year":"2003","unstructured":"Ma L-J, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int Elsevier. 2003;64:350\u20135.","journal-title":"Kidney Int Elsevier"},{"key":"9352_CR40","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest Am Soc Clin Investig. 2010;120:4065\u201376.","journal-title":"J Clin Invest Am Soc Clin Investig"},{"key":"9352_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nm.2290","volume":"17","author":"N Paragas","year":"2011","unstructured":"Paragas N, Qiu A, Zhang Q, Samstein B, Deng S-X, Schmidt-Ott KM, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med Nat Publ Group. 2011;17:216\u201322.","journal-title":"Nat Med Nat Publ Group"},{"key":"9352_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clim.2007.01.010","volume":"123","author":"H Ding","year":"2007","unstructured":"Ding H, He Y, Li K, Yang J, Li X, Lu R, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol Elsevier. 2007;123:227\u201334.","journal-title":"Clin Immunol Elsevier"},{"key":"9352_CR43","first-page":"1505","volume":"50","author":"A Clerico","year":"2012","unstructured":"Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med De Gruyter. 2012;50:1505\u201317.","journal-title":"Clin Chem Lab Med De Gruyter"},{"key":"9352_CR44","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00619.2009","volume-title":"Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition","author":"GJ Ko","year":"2010","unstructured":"Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. MD: Am J Physiol Physiol. American Physiological Society Bethesda; 2010."},{"key":"9352_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority\u2014a WHO resolution. N Engl J Med Mass Med Soc. 2017;377:414\u20137.","journal-title":"N Engl J Med Mass Med Soc"},{"key":"9352_CR46","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama Am Med Assoc. 2016;315:775\u201387.","journal-title":"Jama Am Med Assoc"},{"key":"9352_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccc.2015.11.004","volume":"32","author":"NJ Klingensmith","year":"2016","unstructured":"Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin Elsevier. 2016;32:203\u201312.","journal-title":"Crit Care Clin Elsevier"},{"key":"9352_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40560-018-0356-y","volume":"7","author":"S Otani","year":"2019","unstructured":"Otani S, Coopersmith CM. Gut integrity in critical illness. J intensive care Springer. 2019;7:1\u20137.","journal-title":"J intensive care Springer"},{"key":"9352_CR49","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s15010-018-1178-5","volume":"46","author":"SF Assimakopoulos","year":"2018","unstructured":"Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, et al. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infect Springer. 2018;46:751\u201360.","journal-title":"Infect Springer"},{"key":"9352_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/jgh.13042","volume":"31","author":"K Mori","year":"2016","unstructured":"Mori K, Suzuki T, Minamishima S, Igarashi T, Inoue K, Nishimura D, et al. Neutrophil gelatinase-associated lipocalin regulates gut microbiota of mice. J Gastroenterol Hepatol Wiley Online Libr. 2016;31:145\u201354.","journal-title":"J Gastroenterol Hepatol Wiley Online Libr"},{"key":"9352_CR51","first-page":"1604","volume":"68","author":"H Li","year":"2018","unstructured":"Li H, Feng D, Cai Y, Liu Y, Xu M, Xiang X, et al. Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps. Hepatology Wiley Online Libr. 2018;68:1604\u201320.","journal-title":"Hepatology Wiley Online Libr"},{"key":"9352_CR52","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","volume":"5","author":"M Raffatellu","year":"2009","unstructured":"Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio S-P, Paixao TA, et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe Elsevier. 2009;5:476\u201386.","journal-title":"Cell Host Microbe Elsevier"},{"key":"9352_CR53","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.arcmed.2008.05.003","volume":"39","author":"MH Roudkenar","year":"2008","unstructured":"Roudkenar MH, Halabian R, Ghasemipour Z, Roushandeh AM, Rouhbakhsh M, Nekogoftar M, et al. Neutrophil gelatinase-associated lipocalin acts as a protective factor against H2O2 toxicity. Arch Med Res Elsevier. 2008;39:560\u20136.","journal-title":"Arch Med Res Elsevier"},{"key":"9352_CR54","first-page":"1","volume":"6","author":"T Toyonaga","year":"2016","unstructured":"Toyonaga T, Matsuura M, Mori K, Honzawa Y, Minami N, Yamada S, et al. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci Rep Nat Publ Group. 2016;6:1\u201313.","journal-title":"Sci Rep Nat Publ Group"},{"key":"9352_CR55","first-page":"3875","volume":"4","author":"A Izadi","year":"2016","unstructured":"Izadi A, Yousefifard M, Nakhjavan-Shahraki B, Baikpour M, Mirzay Razaz J, Hosseini M. Diagnostic value of Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in detection of pediatric acute kidney injury; a systematic review and meta-analysis. Int J Pediatr. 2016;4:3875\u201395.","journal-title":"Int J Pediatr"},{"key":"9352_CR56","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2217\/bmm.14.36","volume":"8","author":"SJ McWilliam","year":"2014","unstructured":"McWilliam SJ, Antoine DJ, Sabbisetti V, Pearce RE, Jorgensen AL, Lin Y, et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med Future Med. 2014;8:1189\u201397.","journal-title":"Biomark Med Future Med"},{"key":"9352_CR57","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int Elsevier. 2011;80:806\u201321.","journal-title":"Kidney Int Elsevier"},{"key":"9352_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1159\/000368474","volume":"39","author":"K Helanova","year":"2014","unstructured":"Helanova K, Spinar J, Parenica J. Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases-review. Kidney Blood Press Res Karger Publishers. 2014;39:623\u20139.","journal-title":"Kidney Blood Press Res Karger Publishers"},{"key":"9352_CR59","first-page":"34","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KSL, Kraegen EW, Sweeney G, Zhang J, Tso AWK, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem Oxford Univ Press. 2007;53:34\u201341.","journal-title":"Clin Chem Oxford Univ Press"},{"key":"9352_CR60","first-page":"1","volume":"5","author":"Q Miao","year":"2014","unstructured":"Miao Q, Ku AT, Nishino Y, Howard JM, Rao AS, Shaver TM, et al. Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2. Nat Commun Nat Publ Group. 2014;5:1\u201315.","journal-title":"Nat Commun Nat Publ Group"},{"key":"9352_CR61","first-page":"597","volume":"225","author":"A Sola","year":"2011","unstructured":"Sola A, Weigert A, Jung M, Vinuesa E, Brecht K, Weis N, et al. Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration. J Pathol Wiley Online Libr. 2011;225:597\u2013608.","journal-title":"J Pathol Wiley Online Libr"},{"key":"9352_CR62","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.0510847103","volume":"103","author":"T Berger","year":"2006","unstructured":"Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci National Acad Sci. 2006;103:1834\u20139.","journal-title":"Proc Natl Acad Sci National Acad Sci"},{"key":"9352_CR63","first-page":"1911","volume":"189","author":"G Srinivasan","year":"2012","unstructured":"Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol Am Assoc Immnol. 2012;189:1911\u20139.","journal-title":"J Immunol Am Assoc Immnol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-022-09352-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:25:27Z","timestamp":1744143927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-022-09352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9352"],"URL":"https:\/\/doi.org\/10.1007\/s12026-022-09352-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}